ArticleAdvances in experimental medicine and biology2026
Implementation of Apriori Algorithm to Biomedical Data: Silent Mutations in GWAS-GAD Edition.
Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genome-wide association studies (GWAS) have revolutionized our understanding of genetic contributions to complex diseases by identifying single-nucleotide polymorphisms (SNPs) associated with disease predisposition. Despite the substantial progress made in identifying risk factors for conditions like cancer and cardiovascular diseases, interpreting the functional impact of identified variants remains a challenge, particularly when silent mutations are involved. Silent mutations, once considered irrelevant to disease mechanisms, have emerged as significant players influencing mRNA formation, splicing, and translation processes. This study utilized the Genetic Association Database (GAD) to analyze and identify the significance of silent mutations across a wide range of diseases, employing advanced machine learning techniques and the Apriori algorithm to extract association rules from a biomedical dataset. The Apriori algorithm was applied to identify strong correlations between diseases and chromosomes, using parameters such as support, confidence, and lift to evaluate the strength and importance of these associations. Our results demonstrated the capability of the Apriori algorithm to uncover biologically meaningful relationships, which could be instrumental in improving our understanding of genetic predispositions and guiding precision medicine efforts. These findings underscore the importance of silent mutations in disease etiology and highlight the potential of bioinformatics tools in unraveling complex genetic interactions.
Indexed as
Identifiers
41479101What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.